Intensive Glycemic Management and Outcomes Following Liver Transplantation

NACompletedINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Hospital HyperglycemiaPost-transplant Hyperglycemia
Interventions
OTHER

Intensive glycemic management

Intravenous insulin infusion, strict dietary intervention, carbohydrate matched subcutaneous insulin therapy. This is a multifaceted approach to achieve strict glucose goals of 90 to 120 mg/dL in the ICU and hospital wards.

OTHER

Conventional management

Conventional treatment to control hyperglycemia with a target glucose goal of 120 to 150 mg/dL in the ICU and 140 to 180 mg/dL on the hospital floors.

Trial Locations (1)

32224

Mayo Clinic, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT01432093 - Intensive Glycemic Management and Outcomes Following Liver Transplantation | Biotech Hunter | Biotech Hunter